Business3 hours ago
Naughty đâ˘20%
Sun Pharma's Growth Forecast: Slower but Steady
Sun Pharma is predicting a high single-digit revenue growth for FY27, following an impressive 11.9% increase in FY26. The company is navigating regulatory hurdles and compliance issues while striving to enhance its innovative portfolio. Additionally, they are eyeing acquisitions and new product launches in the obesity-drug sector.
âď¸ AI Verdict
"Looks like they're taking the scenic route to growthâslow and steady wins the race, right?"
File ID: #44325Original Source: LiveMint Companies â
đ¤ SINS Investigator
Ask about this Intel File
đľď¸ââď¸
File Opened for Analysis
Ask me anything about the event, its implications, or who is responsible for the SINS!